About this trial
The aim of the study is to present the quantitative differences in oxygenated hemoglobin in different cohorts.
This clinical study evaluates whether there is a correlation between measurements using multispectral optoacoustic tomography and the results of spiroergometry in the context of performance diagnostics.
Eligibility criteria
Qualifiers
Age ≥ 18 years (adults capable of giving consent)
Capacity to consent. The subjects are able to understand the information provided and give their written consent.
Endurance athletes: at least 3× per week ≥ 60 minutes of intensive endurance training (e.g., running, cycling, swimming)
Strength athletes: at least 3× per week ≥ 60 minutes of intensive strength training without additional endurance training
Disqualifiers
Age over 75 years
Minors (Age < 18)
safety concerns on the part of the study physician, e.g., in the case of of: physical, mental or psychiatric illnesses, acute or chronic conditions that could jeopardise safety or data quality
Taking medications that could affect physical performance or physiological measurements (e.g., heart rate, oxygen uptake).
Trial design
Treatments tested in this trial
- MSOT - Multispectral optoacustic tomography
- CPET
Treatment groups
6
Treatment groupsSee each treatment group below.
Locations
Sponsors and collaborators
University Hospital Erlangen
Lead sponsor
PD Dr. med. Ferdinand Knieling, Department of pediatrics, University of Erlangen-Nürnberg
Collaborator